Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. Should Research Results be Released to Participants in Biospecimen Studies?

   By Guest guest, April 12, 2011
   • 0 replies
   • 28 views
   • 
   • Guest
   • April 12, 2011

2. Re: snip - ODAC minutes - single arm studies for AA

   By Guest guest, April 8, 2011
   • 1 reply
   • 22 views
   • 
   • Guest
   • April 13, 2011

3. Bone Marrow Biopsy Quicker, Less Painful

   By Guest guest, April 14, 2011
   • 0 replies
   • 21 views
   • 
   • Guest
   • April 14, 2011

4. Hallmarks of Cancer Gets an Update

   By Guest guest, April 14, 2011
   • 0 replies
   • 21 views
   • 
   • Guest
   • April 14, 2011

5. Re: NEJM: followup on vitamin D

   By Guest guest, April 14, 2011
   • 0 replies
   • 25 views
   • 
   • Guest
   • April 14, 2011

6. state by state insurance options for people with pre-existing conditions

   By Guest guest, April 15, 2011
   • 0 replies
   • 23 views
   • 
   • Guest
   • April 15, 2011

7. lymphoma and CLL protocols on CT.gov with published results

   By Guest guest, March 6, 2011
   • 0 replies
   • 26 views
   • 
   • Guest
   • March 6, 2011

8. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.

   By Guest guest, March 2, 2011
   • 0 replies
   • 30 views
   • 
   • Guest
   • March 2, 2011

9. for advocates: Accelerated approval overview by FDA - slides

   By Guest guest, March 2, 2011
   • 1 reply
   • 38 views
   • 
   • Guest
   • March 2, 2011

10. Pain Management – A New Blog from The Patient Experience

    By Guest guest, February 28, 2011
    • 0 replies
    • 44 views
    • 
    • Guest
    • February 28, 2011

11. technical: Mechanism of action of lenalidomide

    By Guest guest, February 25, 2011
    • 0 replies
    • 29 views
    • 
    • Guest
    • February 25, 2011

12. Personalizing treatment for chronic lymphocytic leukemia

    By Guest guest, February 24, 2011
    • 1 reply
    • 28 views
    • 
    • Guest
    • February 24, 2011

13. Advancell Announces Positive Phase I/IIa Results With Acadra (Acadesine) in CLL

    By Guest guest, February 28, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • February 28, 2011

14. Telomeric damage in early stage of CLL correlates with shelterin dysregulation

    By Guest guest, March 2, 2011
    • 0 replies
    • 20 views
    • 
    • Guest
    • March 2, 2011

15. Relationship between pharmacokinetic profile of subcoutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia

    By Guest guest, February 24, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • February 24, 2011

16. from LLS: Act Now - Help Fight Off Cancer Research Funding Cuts

    By Guest guest, February 22, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • February 22, 2011

17. Role of rituximab in first-line treatment of chronic lymphocytic leukemia

    By Guest guest, March 2, 2011
    • 0 replies
    • 19 views
    • 
    • Guest
    • March 2, 2011

18. Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

    By Guest guest, March 2, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • March 2, 2011

19. Why Doctors Order Too Many Tests

    By Guest guest, February 25, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • February 25, 2011

20. Signal Transduction Inhibitor Therapy for Lymphoma

    By Guest guest, February 25, 2011
    • 0 replies
    • 21 views
    • 
    • Guest
    • February 25, 2011

21. c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells

    By Guest guest, February 26, 2011
    • 0 replies
    • 32 views
    • 
    • Guest
    • February 26, 2011

22. Double-hit B-cell lymphomas

    By Guest guest, February 26, 2011
    • 0 replies
    • 20 views
    • 
    • Guest
    • February 26, 2011

23. CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

    By Guest guest, February 26, 2011
    • 0 replies
    • 33 views
    • 
    • Guest
    • February 26, 2011

24. Physician Perspectives on Containing the High Cost of Cancer Care

    By Guest guest, February 27, 2011
    • 0 replies
    • 22 views
    • 
    • Guest
    • February 27, 2011

25. CLL PDQ

    By Guest guest, February 28, 2011
    • 0 replies
    • 25 views
    • 
    • Guest
    • February 28, 2011